113 related articles for article (PubMed ID: 35404585)
21. [Free circulating DNA based colorectal cancer screening from peripheral blood: the possibility of the methylated septin 9 gene marker].
Tóth K; Galamb O; Spisák S; Wichmann B; Sipos F; Leiszter K; Molnár J; Molnár B; Tulassay Z
Orv Hetil; 2009 May; 150(21):969-77. PubMed ID: 19443305
[TBL] [Abstract][Full Text] [Related]
22. From discovery to the clinic: the novel DNA methylation biomarker (m)SEPT9 for the detection of colorectal cancer in blood.
Payne SR
Epigenomics; 2010 Aug; 2(4):575-85. PubMed ID: 22121975
[TBL] [Abstract][Full Text] [Related]
23. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
[TBL] [Abstract][Full Text] [Related]
24. Value of methylation markers in colorectal cancer (Review).
Kong C; Fu T
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34212989
[TBL] [Abstract][Full Text] [Related]
25. Genome-wide analysis of DNA methylation identifies two CpG sites for the early screening of colorectal cancer.
Wang X; Wang D; Zhang H; Feng M; Wu X
Epigenomics; 2020 Jan; 12(1):37-52. PubMed ID: 31762318
[No Abstract] [Full Text] [Related]
26. Early detection of the major male cancer types in blood-based liquid biopsies using a DNA methylation panel.
Constâncio V; Nunes SP; Moreira-Barbosa C; Freitas R; Oliveira J; Pousa I; Oliveira J; Soares M; Dias CG; Dias T; Antunes L; Henrique R; Jerónimo C
Clin Epigenetics; 2019 Dec; 11(1):175. PubMed ID: 31791387
[TBL] [Abstract][Full Text] [Related]
27. Aberrant promoter methylation of PPP1R3C and EFHD1 in plasma of colorectal cancer patients.
Takane K; Midorikawa Y; Yagi K; Sakai A; Aburatani H; Takayama T; Kaneda A
Cancer Med; 2014 Oct; 3(5):1235-45. PubMed ID: 24861485
[TBL] [Abstract][Full Text] [Related]
28. Walking pathways with positive feedback loops reveal DNA methylation biomarkers of colorectal cancer.
Kel A; Boyarskikh U; Stegmaier P; Leskov LS; Sokolov AV; Yevshin I; Mandrik N; Stelmashenko D; Koschmann J; Kel-Margoulis O; Krull M; Martínez-Cardús A; Moran S; Esteller M; Kolpakov F; Filipenko M; Wingender E
BMC Bioinformatics; 2019 Apr; 20(Suppl 4):119. PubMed ID: 30999858
[TBL] [Abstract][Full Text] [Related]
29. Colorectal cancer screening with blood-based biomarkers: cost-effectiveness of methylated septin 9 DNA versus current strategies.
Ladabaum U; Allen J; Wandell M; Ramsey S
Cancer Epidemiol Biomarkers Prev; 2013 Sep; 22(9):1567-76. PubMed ID: 23796793
[TBL] [Abstract][Full Text] [Related]
30. Development of a liquid biopsy based purely quantitative digital droplet PCR assay for detection of MLH1 promoter methylation in colorectal cancer patients.
Wang D; O'Rourke D; Sanchez-Garcia JF; Cai T; Scheuenpflug J; Feng Z
BMC Cancer; 2021 Jul; 21(1):797. PubMed ID: 34243735
[TBL] [Abstract][Full Text] [Related]
31. Roles of Methylated DNA Biomarkers in Patients with Colorectal Cancer.
Ma Z; Williams M; Cheng YY; Leung WK
Dis Markers; 2019; 2019():2673543. PubMed ID: 30944663
[TBL] [Abstract][Full Text] [Related]
32. Dual Methylation-Sensitive Restriction Endonucleases Coupling with an RPA-Assisted CRISPR/Cas13a System (DESCS) for Highly Sensitive Analysis of DNA Methylation and Its Application for Point-of-Care Detection.
Wang X; Zhou S; Chu C; Yang M; Huo D; Hou C
ACS Sens; 2021 Jun; 6(6):2419-2428. PubMed ID: 34019391
[TBL] [Abstract][Full Text] [Related]
33. DNA methylation patterns as noninvasive biomarkers and targets of epigenetic therapies in colorectal cancer.
Hashimoto Y; Zumwalt TJ; Goel A
Epigenomics; 2016 May; 8(5):685-703. PubMed ID: 27102979
[TBL] [Abstract][Full Text] [Related]
34. Robust performance of a novel stool DNA test of methylated SDC2 for colorectal cancer detection: a multicenter clinical study.
Wang J; Liu S; Wang H; Zheng L; Zhou C; Li G; Huang R; Wang H; Li C; Fan X; Fu X; Wang X; Guo H; Guan J; Sun Y; Song X; Li Z; Mu D; Sun J; Liu X; Qi Y; Niu F; Chen C; Wu X; Wang X; Song X; Zou H
Clin Epigenetics; 2020 Oct; 12(1):162. PubMed ID: 33126908
[TBL] [Abstract][Full Text] [Related]
35. Quantification of methylated markers with a multiplex methylation-specific technology.
Zou H; Allawi H; Cao X; Domanico M; Harrington J; Taylor WR; Yab T; Ahlquist DA; Lidgard G
Clin Chem; 2012 Feb; 58(2):375-83. PubMed ID: 22194633
[TBL] [Abstract][Full Text] [Related]
36. A two-gene blood test for methylated DNA sensitive for colorectal cancer.
Pedersen SK; Baker RT; McEvoy A; Murray DH; Thomas M; Molloy PL; Mitchell S; Lockett T; Young GP; LaPointe LC
PLoS One; 2015; 10(4):e0125041. PubMed ID: 25928810
[TBL] [Abstract][Full Text] [Related]
37. The influence of methylated septin 9 gene on RNA and protein level in colorectal cancer.
Tóth K; Galamb O; Spisák S; Wichmann B; Sipos F; Valcz G; Leiszter K; Molnár B; Tulassay Z
Pathol Oncol Res; 2011 Sep; 17(3):503-9. PubMed ID: 21267688
[TBL] [Abstract][Full Text] [Related]
38. Quantitative detection of SRY-Box 21 (
Moradi K; Babaei E; Hosseinpour Feizi MA; Safaralizadeh R; Rezvani N
Indian J Cancer; 2021; 58(2):217-224. PubMed ID: 33402569
[TBL] [Abstract][Full Text] [Related]
39. Stool DNA Test of Methylated
Niu F; Wen J; Fu X; Li C; Zhao R; Wu S; Yu H; Liu X; Zhao X; Liu S; Wang X; Wang J; Zou H
Cancer Epidemiol Biomarkers Prev; 2017 Sep; 26(9):1411-1419. PubMed ID: 28619831
[No Abstract] [Full Text] [Related]
40. Sensitive colorimetric biosensing for methylation analysis of p16/CDKN2 promoter with hyperbranched rolling circle amplification.
Geng Y; Wu J; Shao L; Yan F; Ju H
Biosens Bioelectron; 2014 Nov; 61():593-7. PubMed ID: 24956567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
